Menashe Ben‐David

481 total citations
17 papers, 369 citations indexed

About

Menashe Ben‐David is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Menashe Ben‐David has authored 17 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Molecular Biology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Menashe Ben‐David's work include Growth Hormone and Insulin-like Growth Factors (6 papers), Ovarian function and disorders (3 papers) and Sexual Differentiation and Disorders (3 papers). Menashe Ben‐David is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (6 papers), Ovarian function and disorders (3 papers) and Sexual Differentiation and Disorders (3 papers). Menashe Ben‐David collaborates with scholars based in Israel, United States and Chile. Menashe Ben‐David's co-authors include Shmuel Segal, Wolfe Z. Polishuk, Neri Laufer, Haim Yaffe, Joseph G. Schenker, Andreas Chrambach, Andrew V. Schally, Tibor Kádár, J. Edson Pontes and Mátyás Fekete and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, JNCI Journal of the National Cancer Institute and Kidney International.

In The Last Decade

Menashe Ben‐David

16 papers receiving 333 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Menashe Ben‐David Israel 11 179 114 101 53 46 17 369
Marvin C. Hallberg United States 11 245 1.4× 163 1.4× 92 0.9× 26 0.5× 64 1.4× 17 492
Néstor J. Aparicio Argentina 10 147 0.8× 183 1.6× 74 0.7× 15 0.3× 91 2.0× 36 441
S. C. C. YEN United States 7 147 0.8× 113 1.0× 61 0.6× 42 0.8× 85 1.8× 8 411
Cyril A. L. Abrams United States 7 277 1.5× 61 0.5× 102 1.0× 28 0.5× 28 0.6× 13 416
H Kaufman Israel 13 219 1.2× 159 1.4× 186 1.8× 15 0.3× 57 1.2× 42 462
Harvey A. Rubenstein United States 4 343 1.9× 142 1.2× 100 1.0× 26 0.5× 49 1.1× 4 477
Paul G. Cohen United States 9 295 1.6× 91 0.8× 62 0.6× 34 0.6× 22 0.5× 18 462
Migeon Cj United States 9 160 0.9× 56 0.5× 78 0.8× 34 0.6× 33 0.7× 15 333
Kjell Carlström Sweden 9 141 0.8× 70 0.6× 45 0.4× 49 0.9× 55 1.2× 9 406
C. Menéndez Spain 11 243 1.4× 57 0.5× 86 0.9× 27 0.5× 43 0.9× 17 594

Countries citing papers authored by Menashe Ben‐David

Since Specialization
Citations

This map shows the geographic impact of Menashe Ben‐David's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Menashe Ben‐David with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Menashe Ben‐David more than expected).

Fields of papers citing papers by Menashe Ben‐David

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Menashe Ben‐David. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Menashe Ben‐David. The network helps show where Menashe Ben‐David may publish in the future.

Co-authorship network of co-authors of Menashe Ben‐David

This figure shows the co-authorship network connecting the top 25 collaborators of Menashe Ben‐David. A scholar is included among the top collaborators of Menashe Ben‐David based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Menashe Ben‐David. Menashe Ben‐David is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Pierce, L.J., Kelly‐Anne Phillips, Saundra S. Buys, et al.. (2010). 7N Local therapy options in BRCA1/2 carriers with operable breast cancer: the importance of adjuvant chemotherapy. European Journal of Cancer Supplements. 8(3). 55–55.
2.
Kádár, Tibor, Menashe Ben‐David, J. Edson Pontes, Mátyás Fekete, & Andrew V. Schally. (1988). Prolactin and luteinizing hormone‐releasing hormone receptors in human benign prostatic hyperplasia and prostate cancer. The Prostate. 12(4). 299–307. 37 indexed citations
3.
Weizman, Abraham, et al.. (1985). Sulpiride-induced hyperprolactinemia and impotence in male psychiatric outpatients. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 9(2). 193–198. 10 indexed citations
4.
Grunhaus, Leon, et al.. (1983). Prolactin response to the cold pressor test in patients with panic attacks. Psychiatry Research. 8(3). 171–177. 19 indexed citations
5.
Ben‐David, Menashe & Joseph G. Schenker. (1982). Human ovarian receptors to human prolactin: implications in infertility. Fertility and Sterility. 38(2). 182–186. 17 indexed citations
6.
Ben‐David, Menashe, et al.. (1981). On the enumeration of distinct fuzzy switching functions. Fuzzy Sets and Systems. 5(1). 69–81. 2 indexed citations
7.
Ben‐David, Menashe & Andreas Chrambach. (1980). A METHOD FOR ISOLATION BY GEL ELECTROFOCUSING OF ISOHORMONES B AND C OF HUMAN PROLACTIN FROM AMNIOTIC FLUID. Journal of Endocrinology. 84(1). 125–133. 13 indexed citations
8.
Gura, Victor, Abraham Weizman, B. Maoz, Dina Zevin, & Menashe Ben‐David. (1980). Hyperprolactinemia: A Possible Cause of Sexual Impotence in Male Patients Undergoing Chronic Hemodialysis. Nephron. 26(1). 53–54. 11 indexed citations
9.
Segal, Shmuel, Haim Yaffe, Neri Laufer, & Menashe Ben‐David. (1979). Male Hyperprolactinemia: Effects on Fertility. Fertility and Sterility. 32(5). 556–561. 74 indexed citations
10.
Schenker, Joseph G., Menashe Ben‐David, & David M. Albin. (1979). Evidence of Lack of Passage of Human Prolactin through Human Placental Membranes. Gynecologic and Obstetric Investigation. 10(6). 311–319. 10 indexed citations
11.
Halbreich, Uriel, et al.. (1978). Prolactin secretion during and after Noveril infusions to depressive patients. Psychopharmacology. 56(2). 167–171. 11 indexed citations
12.
Perlman, Max, et al.. (1978). Prolonged Hyperprolactinemia in Preterm Infants. The Journal of Clinical Endocrinology & Metabolism. 47(4). 894–897. 16 indexed citations
13.
Yarkoni, Shaul, W.Z. Polishuk, Irving M. Spitz, & Menashe Ben‐David. (1977). Inhibitory Effect of Hyperprolactinemia on Induction of Ovulation by Gonadotropins. Fertility and Sterility. 28(7). 772–774. 7 indexed citations
14.
Segal, Shmuel, Wolfe Z. Polishuk, & Menashe Ben‐David. (1976). Hyperprolactinemic Male Infertility. Fertility and Sterility. 27(12). 1425–1427. 88 indexed citations
15.
Berl, Tomás, et al.. (1976). Osmotic control of prolactin release and its effect on renal water excretion in man. Kidney International. 10(2). 158–163. 28 indexed citations
16.
Rogol, Alan D. & Menashe Ben‐David. (1975). Charge Properties of Human Pituitapy and Amniotic Fluid Prolactins. Endocrine Research Communications. 2(6-7). 379–402. 9 indexed citations
17.
Ben‐David, Menashe, W. E. Heston, & David Rodbard. (1969). Mammary Tumor Virus Potentiation of Endogenous Prolactin Effect on Mammary Gland Differentiation. JNCI Journal of the National Cancer Institute. 42(2). 207–18. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026